

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.23499365 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.96279105 |
| 3 | negative regulation of interleukin-1 beta production (GO:0032691) | 4.75845843 |
| 4 | detection of molecule of bacterial origin (GO:0032490) | 4.75562446 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.33603999 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.33603999 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 4.33603999 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 4.33603999 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 4.33603999 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.33603999 |
| 11 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 4.31299881 |
| 12 | response to peptidoglycan (GO:0032494) | 4.28442710 |
| 13 | positive regulation of growth hormone secretion (GO:0060124) | 4.27451894 |
| 14 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.17213306 |
| 15 | negative regulation of interleukin-1 production (GO:0032692) | 3.98384070 |
| 16 | microglial cell activation (GO:0001774) | 3.95061884 |
| 17 | regulation of gamma-delta T cell activation (GO:0046643) | 3.94958161 |
| 18 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.94779215 |
| 19 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.90541512 |
| 20 | cellular extravasation (GO:0045123) | 3.90198392 |
| 21 | growth hormone receptor signaling pathway (GO:0060396) | 3.90056126 |
| 22 | growth hormone secretion (GO:0030252) | 3.75961888 |
| 23 | detection of external biotic stimulus (GO:0098581) | 3.73314900 |
| 24 | detection of other organism (GO:0098543) | 3.68756896 |
| 25 | positive regulation of steroid hormone secretion (GO:2000833) | 3.63837000 |
| 26 | mannose metabolic process (GO:0006013) | 3.58204499 |
| 27 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.56537735 |
| 28 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.55371246 |
| 29 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.54961512 |
| 30 | macrophage activation involved in immune response (GO:0002281) | 3.46748547 |
| 31 | histone H3-K4 trimethylation (GO:0080182) | 3.45792901 |
| 32 | cellular response to growth hormone stimulus (GO:0071378) | 3.42506832 |
| 33 | nucleoside diphosphate catabolic process (GO:0009134) | 3.39375627 |
| 34 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.39235101 |
| 35 | positive regulation of interferon-alpha production (GO:0032727) | 3.37899651 |
| 36 | response to host immune response (GO:0052572) | 3.37387517 |
| 37 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.37387517 |
| 38 | cellular response to ethanol (GO:0071361) | 3.35840468 |
| 39 | regulation of germinal center formation (GO:0002634) | 3.31002052 |
| 40 | detection of bacterium (GO:0016045) | 3.29699345 |
| 41 | neutrophil activation involved in immune response (GO:0002283) | 3.27834126 |
| 42 | adult feeding behavior (GO:0008343) | 3.27601428 |
| 43 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.22453691 |
| 44 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.22123700 |
| 45 | NAD biosynthetic process (GO:0009435) | 3.20331599 |
| 46 | regulation of interferon-alpha production (GO:0032647) | 3.19024517 |
| 47 | immunoglobulin mediated immune response (GO:0016064) | 3.18755871 |
| 48 | detection of biotic stimulus (GO:0009595) | 3.14577080 |
| 49 | response to muramyl dipeptide (GO:0032495) | 3.11954117 |
| 50 | negative regulation of B cell proliferation (GO:0030889) | 3.11506141 |
| 51 | establishment of protein localization to Golgi (GO:0072600) | 3.04059855 |
| 52 | endocrine hormone secretion (GO:0060986) | 3.03557265 |
| 53 | energy homeostasis (GO:0097009) | 2.97324029 |
| 54 | positive regulation of interferon-beta production (GO:0032728) | 2.93191154 |
| 55 | protein K48-linked deubiquitination (GO:0071108) | 2.90945045 |
| 56 | regulation of glucocorticoid secretion (GO:2000849) | 2.89545414 |
| 57 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.88928792 |
| 58 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.88542676 |
| 59 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.88349514 |
| 60 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.88184434 |
| 61 | positive regulation of circadian rhythm (GO:0042753) | 2.86896052 |
| 62 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.85563656 |
| 63 | response to host (GO:0075136) | 2.84277396 |
| 64 | response to host defenses (GO:0052200) | 2.84277396 |
| 65 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.84277396 |
| 66 | negative regulation of T cell mediated immunity (GO:0002710) | 2.83238455 |
| 67 | cellular response to exogenous dsRNA (GO:0071360) | 2.82740611 |
| 68 | neutrophil activation (GO:0042119) | 2.81766892 |
| 69 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.80859152 |
| 70 | macrophage activation (GO:0042116) | 2.80645549 |
| 71 | negative regulation of interleukin-6 production (GO:0032715) | 2.79369276 |
| 72 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.78169473 |
| 73 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.78072057 |
| 74 | interkinetic nuclear migration (GO:0022027) | 2.76396787 |
| 75 | protein K11-linked deubiquitination (GO:0035871) | 2.75642958 |
| 76 | cellular response to interferon-gamma (GO:0071346) | 2.75111651 |
| 77 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.74746630 |
| 78 | organelle membrane fusion (GO:0090174) | 2.71359082 |
| 79 | regulation of protein glycosylation (GO:0060049) | 2.70830845 |
| 80 | response to type I interferon (GO:0034340) | 2.66441628 |
| 81 | T-helper 1 type immune response (GO:0042088) | 2.64574230 |
| 82 | regulation of penile erection (GO:0060405) | 2.62357766 |
| 83 | cellular response to type I interferon (GO:0071357) | 2.60949074 |
| 84 | type I interferon signaling pathway (GO:0060337) | 2.60949074 |
| 85 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.60493218 |
| 86 | negative regulation of interleukin-12 production (GO:0032695) | 2.60173592 |
| 87 | GTP biosynthetic process (GO:0006183) | 2.59708666 |
| 88 | B cell receptor signaling pathway (GO:0050853) | 2.58859599 |
| 89 | defense response to protozoan (GO:0042832) | 2.58029826 |
| 90 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.57152850 |
| 91 | regulation of corticosteroid hormone secretion (GO:2000846) | 2.55994980 |
| 92 | toxin transport (GO:1901998) | 2.55457808 |
| 93 | skeletal muscle tissue regeneration (GO:0043403) | 2.54368325 |
| 94 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.54168576 |
| 95 | regulation of interleukin-1 beta production (GO:0032651) | 2.53091346 |
| 96 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.52512810 |
| 97 | negative regulation of cell killing (GO:0031342) | 2.52145289 |
| 98 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.52145289 |
| 99 | myeloid cell activation involved in immune response (GO:0002275) | 2.51708489 |
| 100 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.50895268 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.08103252 |
| 2 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.34379471 |
| 3 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.17501283 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.16656776 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.04288757 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.92261045 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.64635845 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.62306095 |
| 9 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.56186868 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.29601422 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.19470211 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.07947410 |
| 13 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.07572907 |
| 14 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.01193258 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.98560611 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.97487720 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.97268701 |
| 18 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.97207856 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.96831155 |
| 20 | SPI1_23127762_ChIP-Seq_K562_Human | 1.94132648 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 1.92422287 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.91196056 |
| 23 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.81583877 |
| 24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.79789863 |
| 25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.76743608 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.75459190 |
| 27 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.73781569 |
| 28 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.67763590 |
| 29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.61483470 |
| 30 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.54767499 |
| 31 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.54245427 |
| 32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.53498738 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.52409171 |
| 34 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.49990072 |
| 35 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48695261 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.46141413 |
| 37 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.46129302 |
| 38 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.45123745 |
| 39 | GATA3_26560356_Chip-Seq_TH2_Human | 1.36446460 |
| 40 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.34197176 |
| 41 | MYB_26560356_Chip-Seq_TH1_Human | 1.33963443 |
| 42 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.32204145 |
| 43 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.28385095 |
| 44 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.28316482 |
| 45 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.28308539 |
| 46 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.27119142 |
| 47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25816769 |
| 48 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.23079844 |
| 49 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.22696334 |
| 50 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.17053307 |
| 51 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.15695326 |
| 52 | VDR_22108803_ChIP-Seq_LS180_Human | 1.15088632 |
| 53 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.13561338 |
| 54 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12546274 |
| 55 | TCF4_23295773_ChIP-Seq_U87_Human | 1.09819506 |
| 56 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.09724037 |
| 57 | STAT3_23295773_ChIP-Seq_U87_Human | 1.09273546 |
| 58 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.09029571 |
| 59 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.08391281 |
| 60 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.07830063 |
| 61 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.06431125 |
| 62 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.05475042 |
| 63 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.04825731 |
| 64 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.04809907 |
| 65 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.04742247 |
| 66 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.03051007 |
| 67 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.02786107 |
| 68 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.01629033 |
| 69 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.00010443 |
| 70 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99995799 |
| 71 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97473337 |
| 72 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97473337 |
| 73 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.97229396 |
| 74 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93758685 |
| 75 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.93077795 |
| 76 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.92303535 |
| 77 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.92303535 |
| 78 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.91625967 |
| 79 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.91376086 |
| 80 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.91203134 |
| 81 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.90882823 |
| 82 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.90882823 |
| 83 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.90865326 |
| 84 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.90654012 |
| 85 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.89504832 |
| 86 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.88511720 |
| 87 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.88034456 |
| 88 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.88005395 |
| 89 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.87817813 |
| 90 | AR_20517297_ChIP-Seq_VCAP_Human | 0.87548824 |
| 91 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87269398 |
| 92 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86870759 |
| 93 | MAF_26560356_Chip-Seq_TH1_Human | 0.86761225 |
| 94 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.86687185 |
| 95 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86480914 |
| 96 | P300_19829295_ChIP-Seq_ESCs_Human | 0.86251964 |
| 97 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85090283 |
| 98 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.84927774 |
| 99 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.84859747 |
| 100 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84761597 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.41962821 |
| 2 | MP0000569_abnormal_digit_pigmentation | 4.37667222 |
| 3 | MP0003724_increased_susceptibility_to | 3.23361703 |
| 4 | MP0003045_fibrosis | 2.96208943 |
| 5 | MP0002396_abnormal_hematopoietic_system | 2.47193334 |
| 6 | MP0001800_abnormal_humoral_immune | 2.46525641 |
| 7 | MP0003436_decreased_susceptibility_to | 2.44332836 |
| 8 | MP0005671_abnormal_response_to | 2.38356511 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.35715199 |
| 10 | MP0003646_muscle_fatigue | 2.25823771 |
| 11 | MP0002419_abnormal_innate_immunity | 2.17251907 |
| 12 | MP0002723_abnormal_immune_serum | 2.16057900 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.08614770 |
| 14 | MP0009785_altered_susceptibility_to | 2.07847380 |
| 15 | MP0005025_abnormal_response_to | 2.07528092 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.01859510 |
| 17 | MP0000685_abnormal_immune_system | 1.92470977 |
| 18 | MP0001790_abnormal_immune_system | 1.91147681 |
| 19 | MP0005387_immune_system_phenotype | 1.91147681 |
| 20 | MP0003303_peritoneal_inflammation | 1.90944860 |
| 21 | MP0001819_abnormal_immune_cell | 1.86326343 |
| 22 | MP0002420_abnormal_adaptive_immunity | 1.85845654 |
| 23 | MP0001853_heart_inflammation | 1.75102656 |
| 24 | MP0005174_abnormal_tail_pigmentation | 1.72084265 |
| 25 | MP0003763_abnormal_thymus_physiology | 1.71581823 |
| 26 | MP0002405_respiratory_system_inflammati | 1.69294089 |
| 27 | MP0008995_early_reproductive_senescence | 1.66523913 |
| 28 | MP0002166_altered_tumor_susceptibility | 1.64927462 |
| 29 | MP0005451_abnormal_body_composition | 1.56770044 |
| 30 | MP0004142_abnormal_muscle_tone | 1.56145972 |
| 31 | MP0009764_decreased_sensitivity_to | 1.53491771 |
| 32 | MP0003866_abnormal_defecation | 1.50172093 |
| 33 | MP0009115_abnormal_fat_cell | 1.48495575 |
| 34 | MP0004883_abnormal_blood_vessel | 1.48219786 |
| 35 | MP0000716_abnormal_immune_system | 1.46287042 |
| 36 | MP0003828_pulmonary_edema | 1.45461787 |
| 37 | MP0001440_abnormal_grooming_behavior | 1.42203754 |
| 38 | MP0001501_abnormal_sleep_pattern | 1.40308684 |
| 39 | MP0002398_abnormal_bone_marrow | 1.38701347 |
| 40 | MP0005266_abnormal_metabolism | 1.38685815 |
| 41 | MP0006054_spinal_hemorrhage | 1.36899468 |
| 42 | MP0003718_maternal_effect | 1.34183813 |
| 43 | MP0002009_preneoplasia | 1.33429717 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.30755890 |
| 45 | MP0006082_CNS_inflammation | 1.25059076 |
| 46 | MP0002148_abnormal_hypersensitivity_rea | 1.25057633 |
| 47 | MP0004484_altered_response_of | 1.22378250 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.21910346 |
| 49 | MP0004381_abnormal_hair_follicle | 1.21372346 |
| 50 | MP0004947_skin_inflammation | 1.16653024 |
| 51 | MP0005395_other_phenotype | 1.15358229 |
| 52 | MP0003191_abnormal_cellular_cholesterol | 1.15084639 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.14018351 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.14018351 |
| 55 | MP0004808_abnormal_hematopoietic_stem | 1.13647066 |
| 56 | MP0000230_abnormal_systemic_arterial | 1.13414707 |
| 57 | MP0000689_abnormal_spleen_morphology | 1.12986809 |
| 58 | MP0002722_abnormal_immune_system | 1.11944599 |
| 59 | MP0002168_other_aberrant_phenotype | 1.10069053 |
| 60 | MP0008961_abnormal_basal_metabolism | 1.09136463 |
| 61 | MP0000427_abnormal_hair_cycle | 1.08540917 |
| 62 | MP0003656_abnormal_erythrocyte_physiolo | 1.08385381 |
| 63 | MP0008260_abnormal_autophagy | 1.08357371 |
| 64 | MP0001533_abnormal_skeleton_physiology | 1.08130199 |
| 65 | MP0002693_abnormal_pancreas_physiology | 1.08083169 |
| 66 | MP0002429_abnormal_blood_cell | 1.07192204 |
| 67 | MP0000465_gastrointestinal_hemorrhage | 1.06356254 |
| 68 | MP0003195_calcinosis | 1.04467925 |
| 69 | MP0005448_abnormal_energy_balance | 1.04452235 |
| 70 | MP0010155_abnormal_intestine_physiology | 1.00244298 |
| 71 | MP0005164_abnormal_response_to | 0.99337345 |
| 72 | MP0004043_abnormal_pH_regulation | 0.98173646 |
| 73 | MP0003279_aneurysm | 0.96843134 |
| 74 | MP0008469_abnormal_protein_level | 0.95696683 |
| 75 | MP0002332_abnormal_exercise_endurance | 0.94894425 |
| 76 | MP0004215_abnormal_myocardial_fiber | 0.93987042 |
| 77 | MP0002006_tumorigenesis | 0.91775373 |
| 78 | MP0004145_abnormal_muscle_electrophysio | 0.91622731 |
| 79 | MP0004130_abnormal_muscle_cell | 0.88475172 |
| 80 | MP0005376_homeostasis/metabolism_phenot | 0.86812878 |
| 81 | MP0003252_abnormal_bile_duct | 0.86153412 |
| 82 | MP0010352_gastrointestinal_tract_polyps | 0.85376002 |
| 83 | MP0005334_abnormal_fat_pad | 0.85009928 |
| 84 | MP0003172_abnormal_lysosome_physiology | 0.84945310 |
| 85 | MP0003690_abnormal_glial_cell | 0.84328122 |
| 86 | MP0001851_eye_inflammation | 0.84037722 |
| 87 | MP0005464_abnormal_platelet_physiology | 0.80320041 |
| 88 | MP0001542_abnormal_bone_strength | 0.80116543 |
| 89 | MP0008877_abnormal_DNA_methylation | 0.79811840 |
| 90 | MP0005058_abnormal_lysosome_morphology | 0.79276060 |
| 91 | MP0003638_abnormal_response/metabolism_ | 0.78147727 |
| 92 | MP0009278_abnormal_bone_marrow | 0.77910744 |
| 93 | MP0003943_abnormal_hepatobiliary_system | 0.77899353 |
| 94 | MP0002095_abnormal_skin_pigmentation | 0.77220774 |
| 95 | MP0005083_abnormal_biliary_tract | 0.77009485 |
| 96 | MP0001986_abnormal_taste_sensitivity | 0.75905664 |
| 97 | MP0002998_abnormal_bone_remodeling | 0.74009114 |
| 98 | MP0002876_abnormal_thyroid_physiology | 0.73475781 |
| 99 | MP0000703_abnormal_thymus_morphology | 0.73051207 |
| 100 | MP0009763_increased_sensitivity_to | 0.68551772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased IgE level (HP:0003212) | 4.68743989 |
| 2 | Genetic anticipation (HP:0003743) | 4.03633139 |
| 3 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.76489760 |
| 4 | Fatigue (HP:0012378) | 3.59075713 |
| 5 | Myositis (HP:0100614) | 3.55733329 |
| 6 | Gaze-evoked nystagmus (HP:0000640) | 3.54981496 |
| 7 | Recurrent cutaneous fungal infections (HP:0011370) | 3.54035854 |
| 8 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.54035854 |
| 9 | Eczematoid dermatitis (HP:0000976) | 3.52071046 |
| 10 | Recurrent abscess formation (HP:0002722) | 3.51126694 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.48719184 |
| 12 | Recurrent fungal infections (HP:0002841) | 3.45165219 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 3.35506285 |
| 14 | Optic neuritis (HP:0100653) | 3.35506285 |
| 15 | Increased cerebral lipofuscin (HP:0011813) | 3.25810112 |
| 16 | Gastrointestinal infarctions (HP:0005244) | 3.21743247 |
| 17 | Orchitis (HP:0100796) | 3.13972862 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.09010446 |
| 19 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.07401381 |
| 20 | Cerebral hemorrhage (HP:0001342) | 3.07123163 |
| 21 | Recurrent bronchitis (HP:0002837) | 3.02810585 |
| 22 | Spontaneous abortion (HP:0005268) | 3.01886323 |
| 23 | Gingival bleeding (HP:0000225) | 2.97207407 |
| 24 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.96894712 |
| 25 | Thrombocytosis (HP:0001894) | 2.93418084 |
| 26 | Recurrent skin infections (HP:0001581) | 2.93149481 |
| 27 | Chest pain (HP:0100749) | 2.91870811 |
| 28 | Progressive cerebellar ataxia (HP:0002073) | 2.86365177 |
| 29 | Chronic sinusitis (HP:0011109) | 2.84080416 |
| 30 | Acute myeloid leukemia (HP:0004808) | 2.76283161 |
| 31 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.72070274 |
| 32 | Loss of speech (HP:0002371) | 2.66363182 |
| 33 | Hemoptysis (HP:0002105) | 2.65645679 |
| 34 | Meningitis (HP:0001287) | 2.65238158 |
| 35 | Parakeratosis (HP:0001036) | 2.63971494 |
| 36 | Obstructive lung disease (HP:0006536) | 2.62570688 |
| 37 | Chronic obstructive pulmonary disease (HP:0006510) | 2.62570688 |
| 38 | Vasculitis (HP:0002633) | 2.60706010 |
| 39 | Inflammation of the large intestine (HP:0002037) | 2.57971832 |
| 40 | Diplopia (HP:0000651) | 2.57720631 |
| 41 | Abnormality of binocular vision (HP:0011514) | 2.57720631 |
| 42 | Erythema (HP:0010783) | 2.50483261 |
| 43 | Macular degeneration (HP:0000608) | 2.48342460 |
| 44 | Arterial thrombosis (HP:0004420) | 2.46339071 |
| 45 | Gangrene (HP:0100758) | 2.42857629 |
| 46 | Autoimmune hemolytic anemia (HP:0001890) | 2.42437924 |
| 47 | Abnormality of T cell physiology (HP:0011840) | 2.39249917 |
| 48 | Stomatitis (HP:0010280) | 2.38397044 |
| 49 | Constricted visual fields (HP:0001133) | 2.34419913 |
| 50 | Clumsiness (HP:0002312) | 2.32557331 |
| 51 | Colitis (HP:0002583) | 2.32060122 |
| 52 | Spontaneous hematomas (HP:0007420) | 2.29763948 |
| 53 | Impaired smooth pursuit (HP:0007772) | 2.28067958 |
| 54 | Abnormality of T cell number (HP:0011839) | 2.27373591 |
| 55 | Abnormality of T cells (HP:0002843) | 2.25333293 |
| 56 | Acute hepatic failure (HP:0006554) | 2.25246340 |
| 57 | Pulmonary infiltrates (HP:0002113) | 2.22858949 |
| 58 | Decreased central vision (HP:0007663) | 2.20649297 |
| 59 | Urticaria (HP:0001025) | 2.18942244 |
| 60 | Keratoconjunctivitis sicca (HP:0001097) | 2.18142896 |
| 61 | Hyperventilation (HP:0002883) | 2.17957681 |
| 62 | T lymphocytopenia (HP:0005403) | 2.17227320 |
| 63 | Impaired vibratory sensation (HP:0002495) | 2.17201839 |
| 64 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.16829699 |
| 65 | Autoimmune thrombocytopenia (HP:0001973) | 2.14766516 |
| 66 | Keratoconjunctivitis (HP:0001096) | 2.14169875 |
| 67 | Mediastinal lymphadenopathy (HP:0100721) | 2.14141978 |
| 68 | Dysmetric saccades (HP:0000641) | 2.13051827 |
| 69 | Sensory axonal neuropathy (HP:0003390) | 2.11602653 |
| 70 | Gastrointestinal inflammation (HP:0004386) | 2.10994191 |
| 71 | Panhypogammaglobulinemia (HP:0003139) | 2.10303042 |
| 72 | Papilledema (HP:0001085) | 2.08541141 |
| 73 | Abnormality of the prostate (HP:0008775) | 2.08420814 |
| 74 | Hypergammaglobulinemia (HP:0010702) | 2.07707464 |
| 75 | Encephalitis (HP:0002383) | 2.07614835 |
| 76 | Abnormality of the columella (HP:0009929) | 2.06729783 |
| 77 | Vertigo (HP:0002321) | 2.05531164 |
| 78 | Areflexia of lower limbs (HP:0002522) | 2.04751512 |
| 79 | Epistaxis (HP:0000421) | 2.03807872 |
| 80 | Hemiplegia (HP:0002301) | 2.01137518 |
| 81 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.99810927 |
| 82 | Leukocytosis (HP:0001974) | 1.98361264 |
| 83 | Frequent falls (HP:0002359) | 1.97837292 |
| 84 | Bronchitis (HP:0012387) | 1.97747796 |
| 85 | Polyneuropathy (HP:0001271) | 1.96342761 |
| 86 | Cheilitis (HP:0100825) | 1.94734944 |
| 87 | Pancreatic cysts (HP:0001737) | 1.94287594 |
| 88 | Abnormality of the pleura (HP:0002103) | 1.93620141 |
| 89 | Prominent nose (HP:0000448) | 1.93438261 |
| 90 | Abolished electroretinogram (ERG) (HP:0000550) | 1.91690827 |
| 91 | Tinnitus (HP:0000360) | 1.91081360 |
| 92 | Cone-rod dystrophy (HP:0000548) | 1.91014820 |
| 93 | Eosinophilia (HP:0001880) | 1.90509258 |
| 94 | Peritonitis (HP:0002586) | 1.87745041 |
| 95 | Exertional dyspnea (HP:0002875) | 1.87040309 |
| 96 | Granulocytopenia (HP:0001913) | 1.86174157 |
| 97 | Gingivitis (HP:0000230) | 1.85999486 |
| 98 | Amaurosis fugax (HP:0100576) | 1.85391917 |
| 99 | Recurrent viral infections (HP:0004429) | 1.83646607 |
| 100 | Amyloidosis (HP:0011034) | 1.83458051 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 4.39027219 |
| 2 | FRK | 3.64169717 |
| 3 | BRD4 | 2.64685155 |
| 4 | STK24 | 2.54887441 |
| 5 | MAP4K1 | 2.48438038 |
| 6 | BLK | 2.46027428 |
| 7 | EPHA3 | 2.36633052 |
| 8 | RIPK4 | 2.28459350 |
| 9 | TLK1 | 2.15037701 |
| 10 | KIT | 2.08432619 |
| 11 | TXK | 1.99218305 |
| 12 | NLK | 1.96175995 |
| 13 | JAK3 | 1.95257882 |
| 14 | PIK3CG | 1.94416968 |
| 15 | TYK2 | 1.92028705 |
| 16 | TEC | 1.82322530 |
| 17 | EPHB1 | 1.81662949 |
| 18 | MAP3K4 | 1.76471974 |
| 19 | MST4 | 1.74891390 |
| 20 | MARK3 | 1.74420596 |
| 21 | IRAK1 | 1.71400895 |
| 22 | CSF1R | 1.71033608 |
| 23 | BMPR2 | 1.69634283 |
| 24 | CAMKK2 | 1.66078807 |
| 25 | BMPR1B | 1.66023506 |
| 26 | JAK1 | 1.53934055 |
| 27 | FGFR3 | 1.50376150 |
| 28 | MAP4K2 | 1.49728854 |
| 29 | BRSK2 | 1.43200581 |
| 30 | SYK | 1.36127030 |
| 31 | JAK2 | 1.34997332 |
| 32 | BTK | 1.32600427 |
| 33 | FES | 1.25449865 |
| 34 | FGR | 1.23604777 |
| 35 | MAP3K6 | 1.23354415 |
| 36 | TNK2 | 1.20005065 |
| 37 | HCK | 1.19815342 |
| 38 | AKT3 | 1.19505353 |
| 39 | CAMK1G | 1.19474818 |
| 40 | ZAP70 | 1.16788242 |
| 41 | ITK | 1.08650454 |
| 42 | IKBKE | 1.06799522 |
| 43 | TGFBR1 | 1.02766888 |
| 44 | CDK19 | 1.02557899 |
| 45 | MAP3K2 | 1.01101999 |
| 46 | LYN | 0.98573824 |
| 47 | PTK2B | 0.96688076 |
| 48 | SIK3 | 0.93310194 |
| 49 | TNIK | 0.93118282 |
| 50 | FLT3 | 0.89856406 |
| 51 | CSK | 0.89540605 |
| 52 | FER | 0.84269477 |
| 53 | MAP2K7 | 0.83946141 |
| 54 | CAMK1D | 0.83113157 |
| 55 | MAP2K4 | 0.82754112 |
| 56 | RET | 0.80221960 |
| 57 | WNK1 | 0.79307628 |
| 58 | FGFR4 | 0.72929640 |
| 59 | MAP3K14 | 0.72451395 |
| 60 | CASK | 0.71968030 |
| 61 | CDK12 | 0.69248026 |
| 62 | STK3 | 0.69050421 |
| 63 | PRKCE | 0.69034524 |
| 64 | IRAK4 | 0.66794908 |
| 65 | SGK2 | 0.63299703 |
| 66 | LRRK2 | 0.62328743 |
| 67 | PAK3 | 0.61421088 |
| 68 | MARK2 | 0.60999172 |
| 69 | GRK7 | 0.60094379 |
| 70 | MAP3K5 | 0.55883879 |
| 71 | MATK | 0.54134228 |
| 72 | PIM1 | 0.54045991 |
| 73 | MAP2K3 | 0.53182828 |
| 74 | LCK | 0.52341296 |
| 75 | NUAK1 | 0.48915663 |
| 76 | PRKAA2 | 0.48021728 |
| 77 | MAPK7 | 0.46581884 |
| 78 | NME1 | 0.44927430 |
| 79 | HIPK2 | 0.44121211 |
| 80 | STK10 | 0.43232748 |
| 81 | NEK9 | 0.42756342 |
| 82 | DMPK | 0.42175898 |
| 83 | IKBKB | 0.41871135 |
| 84 | PRKCQ | 0.41795839 |
| 85 | TGFBR2 | 0.39934507 |
| 86 | PIK3CA | 0.39728105 |
| 87 | MAP2K6 | 0.39636632 |
| 88 | PDGFRB | 0.39491917 |
| 89 | ABL1 | 0.39094091 |
| 90 | ADRBK1 | 0.38854577 |
| 91 | ERBB2 | 0.38411394 |
| 92 | TRPM7 | 0.37527904 |
| 93 | INSRR | 0.36297890 |
| 94 | GRK1 | 0.35959092 |
| 95 | CDC42BPA | 0.35092035 |
| 96 | RPS6KA5 | 0.34459762 |
| 97 | ERBB3 | 0.32785934 |
| 98 | MKNK2 | 0.32399872 |
| 99 | CAMK1 | 0.28409998 |
| 100 | IGF1R | 0.28129023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 4.55006960 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.95005176 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.91097089 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.69795183 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.58502161 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.43996944 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.43040389 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 3.06596281 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.03689821 |
| 10 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.25465990 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.05255100 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 1.95624744 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.88065159 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.86500745 |
| 15 | Influenza A_Homo sapiens_hsa05164 | 1.85721593 |
| 16 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.77591334 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.45142815 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.40215361 |
| 19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.39606976 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.30706352 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.29205407 |
| 22 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.25960523 |
| 23 | Circadian rhythm_Homo sapiens_hsa04710 | 1.21092193 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.17459438 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.17310215 |
| 26 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.14565122 |
| 27 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.11497595 |
| 28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.11023750 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.09935113 |
| 30 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.08109787 |
| 31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.06820190 |
| 32 | Phagosome_Homo sapiens_hsa04145 | 1.01180375 |
| 33 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.94045872 |
| 34 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.90707813 |
| 35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.83699904 |
| 36 | Platelet activation_Homo sapiens_hsa04611 | 0.77982316 |
| 37 | Taste transduction_Homo sapiens_hsa04742 | 0.73804204 |
| 38 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.73343498 |
| 39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.73102593 |
| 40 | Hepatitis C_Homo sapiens_hsa05160 | 0.72884720 |
| 41 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.71498544 |
| 42 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.71208522 |
| 43 | Homologous recombination_Homo sapiens_hsa03440 | 0.68229384 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.67543749 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.64733172 |
| 46 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64142330 |
| 47 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.63258601 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 0.62582175 |
| 49 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.62475862 |
| 50 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60271356 |
| 51 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.59882581 |
| 52 | Peroxisome_Homo sapiens_hsa04146 | 0.57006653 |
| 53 | Olfactory transduction_Homo sapiens_hsa04740 | 0.55350319 |
| 54 | Insulin resistance_Homo sapiens_hsa04931 | 0.54997011 |
| 55 | Hepatitis B_Homo sapiens_hsa05161 | 0.54889310 |
| 56 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.53947546 |
| 57 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.53220502 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.50792865 |
| 59 | Legionellosis_Homo sapiens_hsa05134 | 0.48709794 |
| 60 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.46354469 |
| 61 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45997143 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45192678 |
| 63 | Pertussis_Homo sapiens_hsa05133 | 0.44563465 |
| 64 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.43431264 |
| 65 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42478931 |
| 66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41652251 |
| 67 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.41404190 |
| 68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41178569 |
| 69 | Histidine metabolism_Homo sapiens_hsa00340 | 0.40702334 |
| 70 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.40093855 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38458599 |
| 72 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.36038627 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34255657 |
| 74 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32594876 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.31578135 |
| 76 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.30750011 |
| 77 | Salivary secretion_Homo sapiens_hsa04970 | 0.30630835 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.30559322 |
| 79 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.30342373 |
| 80 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.29435081 |
| 81 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.28965794 |
| 82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.28779732 |
| 83 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.27376899 |
| 84 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.27046905 |
| 85 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.26883910 |
| 86 | Morphine addiction_Homo sapiens_hsa05032 | 0.26552588 |
| 87 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.26114105 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.22970619 |
| 89 | HTLV-I infection_Homo sapiens_hsa05166 | 0.22119189 |
| 90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.21804981 |
| 91 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.20061371 |
| 92 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.19984281 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.19848422 |
| 94 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.19428918 |
| 95 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.19380869 |
| 96 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.19238198 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.18052051 |
| 98 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.17260327 |
| 99 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.16967021 |
| 100 | Cocaine addiction_Homo sapiens_hsa05030 | 0.16897177 |

